Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development
Yun‐Chieh Sung, Ya-Chi Liu, Po-Han Chao, Chih-Chun Chang, Pei-Ru Jin, Ts-Ting Lin, Ja-an Lin, Hui-Teng Cheng, Jane Wang, C. Lai, Ling-Hsuan Chen, A. Y. Wu, Ting-Lun Ho, Tsaiyu Chiang, Dong-Yu Gao, D. Duda, Yunching Chen
Theranostics